Pulmonary Arterial Hypertension

Researchers at the University of Minnesota completed a phase 1, open label study testing the safety of microbiota transplants in patients with Pulmonary Arterial Hypertension. More information about the clinical trial is available here. Read more from the investigators in their publication (link to abstract only, access available upon request to the investigators or a journal subscription).  Investigators are planning a follow up study.